Butyrylcholinesterase (BChE), plays a critical role in alleviating the symptoms of Alzheimer’s disease (AD) by regulating acetylcholine levels, emerging as an attractive target for AD treatment. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.